Core Insights - Shiseido showcased over 50 new products at the 8th China International Import Expo, highlighting its latest achievements in medical aesthetics innovation, product development, and sustainable practices [1] - The launch of the "Shiseido Medical Aesthetic Cycle" and the RQ PYOLOGY brand, developed by a Chinese team, signifies Shiseido's commitment to local co-creation and innovation in the Chinese market [1][2] Group 1: Product Innovations - The RQ PYOLOGY brand features a core technology called "Triple Recombined Collagen Compound Technology," which precisely repairs all skin layers through a specific ratio of collagen types [2] - RQ PYOLOGY introduces a unique "Skin Rhythm Evaluation System" that quantifies skin conditions across six dimensions, providing consumers with detailed skin status reports [2] - The brand offers a comprehensive medical aesthetic skincare solution covering pre-procedure, intra-procedure, post-procedure, and home care phases, supported by a product system that integrates medical devices and imported cosmetics [2] Group 2: Scientific Approach - The "Shiseido Medical Aesthetic Cycle" aims to create a scientific collaborative system between medical aesthetics and home care, establishing a complete and sustainable skincare lifecycle [3] - Leveraging over 500 active ingredients from Shiseido's research library, the system enhances the synergy between medical aesthetics and daily skincare, ensuring superior efficacy [3] - Shiseido emphasizes its commitment to safety and quality by adhering to a mature operational system and safety standards developed over 20 years in Japan's medical aesthetics business [3]